Translating molecular pathology into cancer diagnostics

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/1193630

Funding Status
Status not available

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Precision oncology, the treatment of cancer patients selected with a particular molecular characteristic (biomarker) matched to a therapy, has transformed the treatment of cancer patients. However, many biomarkers used for clinical care are not reliable and do not perform their role. I will translate new research tests from fundamental discovery, clinical trials and the development of novel diagnostics using innovative high throughput laboratory technologies to enhance patient outcomes.

Funded Activity Details

Start Date: 01-01-2020

End Date: End date not available

Funding Scheme: Investigator Grants

Funding Amount: $2,285,520.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

biomarkers | breast cancer | diagnostic methods | oncology

Related Links